Irish Wolfhound Startle Disease (SD), also known as hyperekplexia, is a rare inherited neurological disorder that affects these majestic dogs very early in life, often within 5 to 7 days from birth. Responsible breeding is essential to prevent this condition, which severely compromises the wellbeing of affected puppies.
Research has linked certain genes to this disorder, primarily the SLC6A5 gene mutation. This gene is crucial for the proper function of glycine, an inhibitory neurotransmitter in the central nervous system. Other genes include GLRB, GPHN, and ARHGEF9, all of which play vital roles in glycine neurotransmission.
When mutations impact these genes, it disrupts glycine transport and signalling, which causes the exaggerated startle reflex and other symptoms typical of SD. These chemical messengers normally help regulate muscle control and prevent excessive nerve activity.
Puppies with Startle Disease show rigidity and tremors triggered by tactile touch or sudden noises. They extend all four legs in a stiff posture and cannot stand or walk properly when awake. Notably, symptoms disappear when the puppy is asleep or relaxed.
During suckling, some puppies may stop breathing and show cyanosis (a bluish tint around lips and gums), indicating distress. Affected puppies often weigh less and are smaller compared to their littermates.
A veterinary diagnosis requires a full clinical evaluation. Biopsy or genetic tests such as DNA testing for the SLC6A5 gene mutation confirm carrier status or affected puppies. It is important to rule out other neurological conditions with similar symptoms.
Startle Disease in Irish Wolfhounds is inherited as an autosomal recessive trait. This means a puppy must inherit two mutated copies (one from each parent) to be affected. Dogs with one defective gene copy are carriers but show no symptoms.
Responsible hippological breeding practices including DNA testing and avoiding carrier-to-carrier matings are essential to reduce incidence and improve breed health.
Unfortunately, the prognosis for affected puppies is very poor, given their progressive neurological impairment and distress. Most vets recommend humane euthanasia within the first months of life to prevent suffering.
Breeders and owners are encouraged to prioritise health testing, ethical breeding choices, and compassionate care for affected animals.
Irish Wolfhounds can be screened via DNA tests to identify carriers of the SLC6A5 gene mutation. This is vital for breeders aiming to prevent the disorder.
It is important to remember that testing negative for this gene does not exclude other possible mutations or neurological disorders with similar presentations.
Irish Wolfhound Startle Disease (Hyperekplexia) is a rare, inherited disorder with early onset marked by muscle rigidity and tremors triggered by external stimuli. It severely reduces quality of life in affected puppies, who are often euthanised early on. Responsible DNA testing and breeding strategies are crucial to manage and reduce this condition in the breed.